⏳ Fetching live dividend data...
Home › Calculator › BIESF Dividend Calculator 2026
Biotest AG · OTC
Price: $32.00 · Annual div: $0.05/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
BIESF is not a dividend-focused stock
BIESF pays a very low or no dividend (Yield: 0.15%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in BIESF → $187.4K in 10 years · $1.23/month
Biotest Aktiengesellschaft, a German biopharmaceutical company established in Dreieich in 1946, specializes in the research, development, production, and global commercialization of advanced biological therapeutics. Its operations are organized into key segments: Therapy, Plasma & Services, and Other. The company’s primary focus areas encompass critical medical needs within hematology (blood disorders), clinical immunology, and intensive care medicine. Biotest offers a comprehensive range of products, including specific treatments for hemophilia like Haemoctin and Vihuma for the acute and prophylactic management of hemophilia A, and Haemonine for similar applications in hemophilia B. Its portfolio also features immunotherapies such as Cytotect CP biotest for cytomegalovirus infections, Fovepta for hepatitis B prophylaxis in neonates, and Hepatect for preventing hepatitis B reinfection. Varitect addresses varicella zoster virus infections, while Intratect and IgG Next Generation are utilized for primary immune and secondary antibody deficiency syndromes, autoimmune conditions, and certain neurological indications. Additionally, Zutectra is available for hepatitis B re-infection prophylaxis following liver transplantation. Further extending its product line, Biotest provides solutions like Albiomin and Biseko to restore and sustain circulating blood volume, Cofact for clotting factor deficiencies, and Fibrinogen for congenital fibrinogen deficiency. Innovative treatments include Trimodulin for community-acquired pneumonia and COVID-19, as well as Pentaglobin for bacterial infections. Known as Biotest Serum-Institut GmbH until its renaming in 1986, the company has been operating as a subsidiary of Grifols, S.A. since January 21, 2022.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BIESF position with:
Real after-tax yield depends on where you live and how you hold BIESF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.15% | -2.65% | $15 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.13% | -2.67% | $13 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.12% | -2.68% | $12 / yr |
| 🇬🇧 UK ISA | 0% | 0.15% | -2.65% | $15 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.14% | -2.66% | $14 / yr |
| 🇨🇦 TFSA | 0% | 0.15% | -2.65% | $15 / yr |
| 🇨🇦 CA Taxable | 25% | 0.11% | -2.69% | $11 / yr |
| 🇦🇺 Super (pension) | 15% | 0.13% | -2.67% | $13 / yr |
| 🇦🇺 AU Taxable | 30% | 0.10% | -2.69% | $11 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.11% | -2.69% | $11 / yr |
| 🇫🇷 FR Taxable | 30% | 0.10% | -2.69% | $11 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.05/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
BIESF pays quarterly — 4 times per year. Next ex-div: TBD.
How BIESF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BIESF sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BIESF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Biotest AG (BIESF) is currently trading at $32.00, 34% below its 52-week high. The current dividend yield is 0.15% based on an annual payout of $0.05 per share.
Biotest AG (BIESF) is a healthcare stock currently trading at $32.00 with a dividend yield of 0.15%. The company pays an annual dividend of $0.05 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →